<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
	<channel>
	<link>http://salesandmarketingnetwork.com/reports_summary.php</link>
	<title>Healthcare Sales &amp; Marketing Network: Market Research Marketplace</title>
	<description><![CDATA[Authoritative, up-to-the-minute reports and analysis of the medical device and biopharmaceutical market sectors]]></description>
	<lastBuildDate>Thu, 24 Jul 2008 22:05:47 CST</lastBuildDate>
	<language>en-us</language>
	<image>
	<title><![CDATA[The Healthcare Sales & Marketing Network]]></title>
	<width>150</width>
	<height>67</height>
	<link>http://salesandmarketingnetwork.com/reports_summary.php</link>
	<url>http://salesandmarketingnetwork.com/images/hsmn_logo_150.gif</url>
	</image>
	<item>
		 <title><![CDATA[Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2636</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Leading Drug Delivery Companies and Technologies
Competitive landscape, company profiles and technological developments

Business Intelligence for the Pharmaceutical Industry

Business Insights' portfolio of healthcare management reports is designed t... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: Jun-08</font><br/><font color="teal">Pages: 175</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Innovations in The Management of Diabetes: Next generation treatments and market dynamics]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2635</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Innovations in the Management of Diabetes
Next generation treatments and market dynamics

Business Intelligence for the Pharmaceutical Industry
Business Insights' portfolio of healthcare management reports is designed to help you make well informed and... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: Jun-08</font><br/><font color="teal">Pages: 111</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Monoclonal Antibodies Report: 2008 Update]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2634</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2013 and assessing trends by product, company, therapy area, technology and target type. It also provides an... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: 6-Jun-08</font><br/><font color="teal">Pages: 363</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2633</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The neuropathic pain market is forecast to almost triple to over $6.3 billion by the end of the forecast period in 2017. The growth in the market is spurred on by the uptake of Pfizer's Lyrica (pregabalin), forecast to reach almost $3 billi... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: 16-Jun-08</font><br/><font color="teal">Pages: 239</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2632</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The treatment of menopausal symptoms is a common clinical challenge, with vasomotor symptoms affecting an estimated 75% of women aged over 50 years. Hormone replacement therapy (HRT) has formed the mainstay of treatment for almost 60 years ... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: 17-Jun-08</font><br/><font color="teal">Pages: 135</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2639</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[As Kalorama publishes its second edition of this detailed report on the long term care industry and all of its segments, there is no decrease in demand or activity for everything from nursing homes, to home care, to hospices.  The U.S. long care industry h... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: 7/1/2008</font><br/><font color="teal">Pages: 200</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2638</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly.  (China’s pharmaceutical market, for instance, is expected to show double-digit growth over th... <br/><font color="red">Category:  Editor's Choice Reports</font><br/><font color="blue">Published: 7/1/2008</font><br/><font color="teal">Pages: 125</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World Wound Care Markets 2008 (Sales and Key Trends in the Treatment of Burns, Skin Ulcers, Surgical and Trauma Wounds)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2631</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[2008 has seen no decrease in attention on wound care products.  The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry.   For market watchers, this makes for a dynamic market th... <br/><font color="red">Category: Wound Care</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 150</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World Wound Care Markets 2008 (Sales and Key Trends in the Treatment of Burns, Skin Ulcers, Surgical and Trauma Wounds)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2614</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[2008 has seen no decrease in attention on wound care products.  The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry.   For market watchers, this makes for a dynamic market th... <br/><font color="red">Category: Wound Care</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 150</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Wireless in Healthcare 2008 (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2629</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[2008 has not seen any letdown in the use of wireless technologies in healthcare settings.  The clinical environment is a highly mobile one, and physicians, nurses and other clinical operators have a real need for fast information they can act upon.  Wirele... <br/><font color="red">Category: Wireless</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Major World Markets for Stents and The Economics of Drug-Eluting Technology 
]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2627</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Since the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market:  After numerous clinical studies and mixed cost-effectiveness r... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 125</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Major World Markets for Stents and The Economics of Drug-Eluting Technology 
]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2610</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Since the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market:  After numerous clinical studies and mixed cost-effectiveness r... <br/><font color="red">Category: Medical Devices</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 125</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World OTC Pharmaceutical Markets]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2630</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Over-the-counter (OTC) drugs are non-prescription, non-legend, drugs sold to consumers by convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self... <br/><font color="red">Category: OTC</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Outsourcing in Drug Discovery, 3rd Edition 
]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2628</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons.  New technologies increase the number of targets and accelerate the identification of active compounds.  There is increasing pressure to devel... <br/><font color="red">Category: Drug Development</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Drug Repositioning Strategies - Serendipity by design]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2626</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly h... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 8-May-08</font><br/><font color="teal">Pages: 93</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2625</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

With several recent non-approvable decisions in the osteoarthritis market since 2006, Datamonitor has updated its forecast to account for the effect on the market. We have revised the market outlook over the next 10 years using the latest I... <br/><font color="red">Category: Arthritis</font><br/><font color="blue">Published: 23-May-08</font><br/><font color="teal">Pages: 71</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2624</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Stroke is one of the top three causes of death and its incidence in the seven major markets is expected to increase in the next ten years because of an aging population. Long term disability caused by stroke is a major economic burden on he... <br/><font color="red">Category: Neurology</font><br/><font color="blue">Published: 23-May-08</font><br/><font color="teal">Pages: 295</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Online patient recruitment and its impact on patient relationship management]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2623</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

With the rising costs, length and complexity of clinical trials, drug development is subject to huge delays, translating into delays in getting a drug to market and millions of dollars in lost sales. Optimizing the recruitment process throu... <br/><font color="red">Category: Clinical Trials</font><br/><font color="blue">Published: 23-May-08</font><br/><font color="teal">Pages: 67</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline Insight: Non-insulin antidiabetics – Incretin mimetics – leaders in a diverse pipeline]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2622</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Datamonitor expects incretin mimetics to emerge as a major new therapeutic class in non-insulin antidiabetics, driven by an explosion in the patient population, safety fears surrounding established therapies and significant unmet patient ne... <br/><font color="red">Category: Endocrinology</font><br/><font color="blue">Published: 28-May-08</font><br/><font color="teal">Pages: 294</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pricing & Reimbursement - Seven Major Markets Update]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2621</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Governments and payers across the seven major markets are implementing cost-cutting initiatives to combat escalating healthcare costs, putting even greater pressure on pharma companies. In addition to the credit crunch, ever fewer novel pro... <br/><font color="red">Category: Reimbursement</font><br/><font color="blue">Published: 28-May-08</font><br/><font color="teal">Pages: 119</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2620</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Innovative Clinical Trial Design and Management
Trends, success stories and impact upon R&D budgets
Report overview Key findings...
The costs associated with developing drugs have risen dramatically over the past decade and fewer drugs are obtaining reg... <br/><font color="red">Category: Clinical Trials</font><br/><font color="blue">Published: May-08</font><br/><font color="teal">Pages: 170</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2619</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Emerging Role of Postmarketing Clinical Research: Regulatory Compliance, Product Differentiation and Key Issues

Report overview

The pharmaceutical industry has recently endured intense speculation and negative publicity as a result of high profile pr... <br/><font color="red">Category: General</font><br/><font color="blue">Published: May-08</font><br/><font color="teal">Pages: 121</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Contract Manufacturing Strategies: Market developments, technology transfer and key success factors]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2618</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Contract Manufacturing Strategies
Drug manufacturing now typically accounts for 25% of company costs and achieving agility in the production process has become essential for pharma companies hoping to align their supply chains with constant shifts in glob... <br/><font color="red">Category: Contract Manufacturing</font><br/><font color="blue">Published: May-08</font><br/><font color="teal">Pages: 165</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2617</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Nanotechnologies have already attracted over $3bn of global government funding as part of efforts to enhance a range of disciplines including pharmaceuticals, drug delivery and healthcare monitoring. Advances in nanomaterials, nanostructures and nanosystem... <br/><font color="red">Category: Drug Development</font><br/><font color="blue">Published: Jan-08</font><br/><font color="teal">Pages: 192</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Innovations in Bioinformatics: Emerging tools for drug discovery and development]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2616</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Innovations in Bioinformatics
Emerging tools for drug discovery and development
Report overview 
R&D laboratories are co-ordinating the analysis of increasing volumes of disparate biological data, largely comprised of gene and protein sequences. Bioinfo... <br/><font color="red">Category: Drug Development</font><br/><font color="blue">Published: Jan-08</font><br/><font color="teal">Pages: 253</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Launching Combination Products: Brand extension and franchise development strategies]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2615</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Launching Combination Products
Brand extension and franchise development
Business Intelligence for the Pharmaceutical Industry
Business Insights' portfolio of healthcare management reports are designed to help you make well informed and timely business ... <br/><font color="red">Category: General</font><br/><font color="blue">Published: Feb-08</font><br/><font color="teal">Pages: 101</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Allos Therapeutics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2569</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of cancer. The company’s lead product candidate, PDX, is currently in Phase II/I for various cancers. This... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Anesiva Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2573</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Anesiva (previously Corgentech), based in South San Francisco, California, is a late stage biotechnology company with two product candidates: Zingo and Altea for the potential treatment of various pain management indications. The company me... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 49</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Antisoma plc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2570</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Antisoma is a development stage biotechnology company focused on the development of novel anticancer drugs. The Company has built a diversified product pipeline based on in-licensing and acquisitions that target a variety of tumors by diffe... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 42</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Avigen Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2590</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Avigen is a development stage biopharmaceutical company focusing on small molecule therapeutics and biologics to treat neurological and neuromuscular disorders. The company’s current pipeline products primarily address spasticity and neurom... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 39</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Beckman Coulter Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2571</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Beckman Coulter is a manufacturer of medical devices and diagnostic kits used to conduct basic research for developing vaccines and drugs to treat diseases, to conduct preclinical and clinical development, and to perform simple patient bloo... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 56</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Becton, Dickinson and Co: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2609</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Becton, Dickinson and Company (BD), a medical technology company, improves drug therapy, enhances the diagnosis of infectious diseases and advances drug discovery. It manufactures and sells a broad range of medical supplies, devices, labora... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 55</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[BIOMS Medical Corp: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2572</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 35</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Boston Scientific Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2574</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Boston Scientific is one of the leading companies in less-invasive medical devices market offering more than 15,000 products in over 45 countries across the world under the four core business groups: cardiovascular, endosurgery, neuromodula... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 67</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[C.R. Bard Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2591</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

C.R. Bard (Bard), which celebrated its centenary in 2007, is one of the leading global developer, manufacturer and marketer of medical technologies in the fields of vascular, urology, oncology and surgical specialty products. The company ha... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 57</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Carl Zeiss Meditec AG: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2575</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Carl Zeiss Meditec is an integrated medical technology company that develops, manufactures and markets diagnostic and therapeutic systems for the treatment of vision defects, cataracts, glaucoma and retinal disorders. The company operates i... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 42</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cougar Biotechnology Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2603</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Cougar Biotechnology is a development stage biopharmaceutical company engaged in acquiring and developing products for the treatment of cancer. The company has built its development portfolio through in-licensing product candidate strategy.... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 39</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[CSL Limited: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2578</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

CSL is a global, specialty biopharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products of biological origin such as vaccines and plasma protein biotherapies. It operates globally throug... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 74</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cytori Therapeutics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2602</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Cytori Therapeutics (previously MacroPore Biosurgery), based in San Diego, California, is one of the leading companies in the development and commercialization of regenerative medicine products.

Scope

Contains corporate strategy, valu... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Danaher Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2592</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Danaher is a diversified technology company engaged in designing, manufacturing and marketing of professional, medical, industrial and consumer products with strong brand names and significant market positions.

Scope

Contains corporate stra... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 48</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Illumina Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2599</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Illumina is one of the leading companies in genome and genotyping market. The company’s proprietary technology enables conversion of raw sequence data from the human genome into medically relevant information. The January 2007 acquisition of ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Incyte Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2584</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Incyte is a development stage company involved in drug discovery and development activities with major focus on developing small molecule drugs to treat various diseases. The company has proprietary product pipeline in various stages of dev... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Introgen Therapeutics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2606</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Introgen Therapeutics (Introgen) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer. The company has been successful in developing a strong ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 53</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Javelin Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2581</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Javelin Pharmaceuticals is a late development stage specialty pharmaceutical company that discovers, develops and commercializes drugs and improved formulations of existing drugs that target pain management market.

Scope

Contains corp... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 48</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[KV Pharmaceutical Company: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2589</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

KV Pharmaceutical is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The company received t... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 61</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[La Jolla Pharmaceutical Co: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2587</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

La Jolla Pharmaceutical (La Jolla) is a development stage biotechnology company focused entirely on novel antibody therapies for specific autoimmune diseases. The company’s only clinical stage candidate, Riquent, is being studied in Phase I... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 38</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Lev Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2605</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Lev Pharmaceuticals is a development stage biopharmaceutical company engaged in developing and commercializing therapeutics based on C1-esterase inhibitor (C1-INH) for the treatment of inflammatory diseases. Cinryze, the company’s lead drug... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 34</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Lexicon Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2588</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockou... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 51</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[LifeCell Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2600</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

LifeCell Corporation (LifeCell) develops, processes and markets biologically-based products in the emerging field of regenerative medicine. The company's proprietary human tissue matrix has been successfully used in more than 1 million graf... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[MannKind Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2601</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

MannKind, a development-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic products for metabolical disorder and cancer. Technosphere Insulin (TI) System is the company's lead product candidate ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Medtronic Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2593</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Medtronic is a diversified medical technology company engaged in manufacturing a range of medical devices and therapies for the treatment of heart and vascular disease, neurological disorders, chronic pain, spinal disorders, diabetes, urolo... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 68</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Micromet Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2579</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Micromet’s main focus is to develop and commercialize products for the treatment of cancer and inflammatory and autoimmune diseases. The company continues to leverage the capability for their early-stage development collaborations as well a... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[MorphoSys AG: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2604</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

MorphoSys is a biotechnology company focused on the research and development of antibody drugs. The company’s main technology platform includes HuCAL (Human Combinatorial Antibody Library), an innovative technology which allows rapid and au... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Novacea Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2598</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Novacea is a development stage biopharmaceutical company engaged in in-licensing, developing and commercializing of novel therapies for the treatment of diseases in the therapeutic area of oncology. The company’s lead candidate, Ascenter, i... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 39</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Nuvelo Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2583</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Nuvelo is a biopharmaceutical company that is focused on the discovery, development, and commercialization of novel drugs for acute cardiovascular and cancer therapy primarily in the US. The company’s lead candidate, NU172, is a Phase I pro... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Optimer Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2580</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Optimer is a biopharmaceutical company focused on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The Company currently has two late stage anti-infective p... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 40</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Panacos Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2586</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Panacos Pharmaceuticals is a development stage biotechnology company specialized in developing antiviral products for the treatment of patients with HIV infection. The company’s lead drug candidate, bevirimat (formerly PA-457) is an HIV mat... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 44</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Poniard Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2608</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Poniard Pharmaceuticals, formerly known as NeoRx Corporation, is a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapy products. The company’s lead product candidate, Picoplatin, is curren... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 41</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Smith & Nephew plc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2594</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Smith & Nephew is a diversified medical technology group specializing in orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management products. The group acquired two companies, Plus Orthope... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 67</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Spectrum Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2582</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Spectrum Pharmaceuticals (Spectrum) is a biopharmaceutical company with a diversified portfolio of generic products and a pipeline of proprietary and collaborative products. Its therapeutic focus is on various cancer indications, infections... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[St. Jude Medical Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2597</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

SJM develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices. The company has ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 59</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stryker Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2585</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Stryker Corporation (Stryker) develops, manufactures and markets medical devices and instrumentations in the orthopedic as well the other medical surgical markets. While it is best known for its orthopedic products, it also has a material p... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 59</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Theratechnologies Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2607</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Theratechnologies is a Canadian biopharmaceutical company developing therapeutic peptides for endocrine and metabolic disorders. The company has developed its product pipeline utilizing two technologies ExoPep and LAP (Long Acting Peptide).... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[TorreyPines Therapeutics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2596</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

TorreyPines Therapeutics is a San-Diego-based biotechnology company formed through a reverse-merger with publicly-held Axonyx in October 2006. Previously known as Neurogenetics, TorreyPines is focused on the discovery and development of nov... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 47</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Transition Therapeutics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2595</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. The company’s patented drug discovery technologies have helped the company in expanding its pipeline portfolio... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Varian Medical Systems Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2577</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Varian Medical Systems (Varian) is one of the leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company is also a sup... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 56</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Zimmer Holdings Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2576</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Founded in 1927, Zimmer Holdings is a diversified international orthopedic company with share leadership in multiple product categories including the $10 billion hip and knee replacement market.

Scope

Contains corporate strategy, valu... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 22-Apr-08</font><br/><font color="teal">Pages: 56</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Wireless in Healthcare 2008 (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2612</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[2008 has not seen any letdown in the use of wireless technologies in healthcare settings.  The clinical environment is a highly mobile one, and physicians, nurses and other clinical operators have a real need for fast information they can act upon.  Wirele... <br/><font color="red">Category: Medical Devices</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World OTC Pharmaceutical Markets]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2613</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Over-the-counter (OTC) drugs are non-prescription, non-legend, drugs sold to consumers by convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self... <br/><font color="red">Category: OTC</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Outsourcing in Drug Discovery, 3rd Edition 
]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2611</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons.  New technologies increase the number of targets and accelerate the identification of active compounds.  There is increasing pressure to devel... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 5/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Portable Inhaler Devices - Key tools to differentiate brands and survive generic pressure]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2568</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

An overview ofthe market for portable inhalers, looking at market shares,usefulness as tools for franchise protection and -expansion. Patient- and physician preferences are being analyzed as well as suitablility of molecules and inhaler typ... <br/><font color="red">Category: Allergy & Respiratory</font><br/><font color="blue">Published: 2-Apr-08</font><br/><font color="teal">Pages: 159</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2567</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
The ADHD market is currently valued at $3.85 billion and is set to increase over the next 10 years at a CAGR of 1.2%. Despite the continuing dominance of stimulant drugs, the 2002 launch of Strattera, the first non-stimulant treatment for ADH... <br/><font color="red">Category: Pharma Pipeline</font><br/><font color="blue">Published: 10-Apr-08</font><br/><font color="teal">Pages: 211</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2566</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
Incidence of breast cancer in the seven major markets will total 455,000 in 2008, while 115,000 women will die from the disease. Despite advances in treatment over the past decade, significant unmet needs remain. This level of demand and the ... <br/><font color="red">Category: Oncology</font><br/><font color="blue">Published: 17-Apr-08</font><br/><font color="teal">Pages: 187</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Heart Failure - When drugs do not work]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2565</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
Advanced heart failure is a growing issue. Existing pharmacological strategies increase the survival rates of acute heart failure patients, providing a growing source of patients with advanced disease. In view of long waiting lists for heart ... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: 17-Apr-08</font><br/><font color="teal">Pages: 146</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2564</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
Non-small cell lung cancer accounts for about 80% of all lung cancers. In 2008, the incidence of NSCLC is forecast to exceed 367,000 new cases in the seven major pharmaceutical markets. The high incidence of the disease and the large unmet ne... <br/><font color="red">Category: Oncology</font><br/><font color="blue">Published: 17-Apr-08</font><br/><font color="teal">Pages: 266</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2563</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
As the reimbursement status for the cost of hospital-acquired infections is under pressure by payors, interest in preventing these complications at the outset is growing. Nosocomial vaccines offer one route of prevention. This report assesses... <br/><font color="red">Category: Vaccines</font><br/><font color="blue">Published: 17-Apr-08</font><br/><font color="teal">Pages: 205</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial and Pipeline Insight: HRT for Menopausal Symptoms – A new class restores an old market]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2562</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
In 2007, the market value of HRT for menopausal symptoms saw its first upturn since the Women’s Health initiative (WHI) study results in 2002; highly publicized findings which linked HRT to cancer and cardiovascular safety risks. The recent g... <br/><font color="red">Category: Women's Health</font><br/><font color="blue">Published: 17-Apr-08</font><br/><font color="teal">Pages: 159</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2561</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
The market for CNS drugs across the 7MM was worth a substantial $95.5 billion, accounting for a 21.4% share of the total pharmaceutical market value in 2007. Despite stalling R&D productivity and the genericization of the majority of leading ... <br/><font color="red">Category: Neurology</font><br/><font color="blue">Published: 17-Apr-08</font><br/><font color="teal">Pages: 411</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2560</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction
While drug eluting stents have been successful in reducing the rate of restenosis following percutaneous coronary intervention, there have been safety scares over a new problem: “in-stent thrombosis”. Opinion leaders are divided over the grav... <br/><font color="red">Category: Medical Devices</font><br/><font color="blue">Published: 23-Apr-08</font><br/><font color="teal">Pages: 95</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2559</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Drug Approval Trends at the FDA and EMEA
Process improvements, heightened scrutiny and industry response


Business Intelligence for the Pharmaceutical Industry

Business Insights' portfolio of healthcare management reports is designed to help you ma... <br/><font color="red">Category: FDA</font><br/><font color="blue">Published: Apr-08</font><br/><font color="teal">Pages: 147</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2558</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[The Convergence of Biomarkers and Diagnostics
Therapy area analyses, key products and future trends

In recent years, there have been concerted efforts to enhance the precision of disease diagnosis and monitoring as the hetrogeneity of conditions become... <br/><font color="red">Category: Diagnostics</font><br/><font color="blue">Published: Apr-08</font><br/><font color="teal">Pages: 265</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Clinical Diagnostics in China: Market Analysis and Participant Directory]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2557</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[The Chinese market represents a significant opportunity for IVD diagnostic companies. But actionable information about this emerging market is often difficult to get. Only with an exhaustive, on-the-ground research team can a company truly understand the c... <br/><font color="red">Category: Diagnostics</font><br/><font color="blue">Published: 1/15/2008</font><br/><font color="teal">Pages: 260</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Clinical Diagnostics In Mexico: Market Analysis and Participant Directory]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2556</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Mexico is an important market for diagnostic companies and distributors.  But information is difficult to obtain. Published in partnership with McEvoy and Farmer, who have long been known for the best on the ground market research in world diagnostics, Cli... <br/><font color="red">Category: Diagnostics</font><br/><font color="blue">Published: 1/18/2008</font><br/><font color="teal">Pages: 175</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Molecular Diagnostics in China]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2555</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[For 12+ years, the team of Carl McEvoy and Michael Farmer have conducted exhaustive on-the-ground research in Asia, and most notabably China, interviewing lab employees and executives to obtain an accurate picture of the IVD market in China and other count... <br/><font color="red">Category: Diagnostics</font><br/><font color="blue">Published: 2/1/2008</font><br/><font color="teal">Pages: 70</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World Market for Prescription Generic Drugs, 6th Edition]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2554</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry.  While growth indications are strong, there are challenges for generic companies.  In the next two years, consolidation wil... <br/><font color="red">Category: Generics</font><br/><font color="blue">Published: 4/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, The]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2553</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008.  Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last ... <br/><font color="red">Category: Vaccines</font><br/><font color="blue">Published: 4/1/2008</font><br/><font color="teal">Pages: 230</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies, The]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2552</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as ... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 4/1/2008</font><br/><font color="teal">Pages: 52</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Biogenerics, The World Market: Biosimilars and Follow-On Biologics at a Crossroads]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2551</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Worldwide interest in biogenerics or biosimilars is gaining momentum.  Since Kalorama Information last visited the market for synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies four years ago,... <br/><font color="red">Category: Generics</font><br/><font color="blue">Published: 4/1/2008</font><br/><font color="teal">Pages: 153</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Improving Efficiencies through the Development of Claims Processing in Healthcare (Strategic Focus)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2550</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

In challenging market conditions that healthcare payers are faced with this report analyzes the claims processing market for healthcare payers. The report looks at how claims processing can bring an increased return on investment (ROI) to p... <br/><font color="red">Category: Reimbursement</font><br/><font color="blue">Published: 26-Mar-08</font><br/><font color="teal">Pages: 32</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Addressing Key Challenges in Drug Safety (Strategic Focus)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2549</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

High profile drug withdrawals and negative public attention has placed drug safety at the top of the pharmaceutical industry's agenda. This report will examine pharmacovigilance technology solutions designed to alleviate the challenges in d... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 26-Mar-08</font><br/><font color="teal">Pages: 34</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Claims Processing for Healthcare Payers (Market Model)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2548</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

This model sizes the market for claims processing in healthcare payers from 2007-2013. The model is segmented into government and private payers. In addition the market is broken down between BPO and in-house services.

Reasons to Purchas... <br/><font color="red">Category: Reimbursement</font><br/><font color="blue">Published: 26-Mar-08</font><br/><font color="teal">Pages: 0</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Emerging pharmaceutical markets Argentina and Mexico]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2547</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Latin American countries have attracted a lot of attention recently. With their economies currently stable, their geographic location and low-cost is ideal for investors. In addition, having such a high and varied population eases recruitme... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 12-Mar-08</font><br/><font color="teal">Pages: 106</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2546</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Bone metastases are a complication of some advanced cancers including cancers of the breast, lung, prostate, kidney and thyroid. The incidence of bone metastases across these tumor types in the seven major markets is forecasted to total 225... <br/><font color="red">Category: Oncology</font><br/><font color="blue">Published: 20-Mar-08</font><br/><font color="teal">Pages: 100</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2545</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Today, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 20-Mar-08</font><br/><font color="teal">Pages: 187</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2544</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

SLE is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares. Therapy is largely off-label and a huge demand exists for new SLE therapies because of the potential fo... <br/><font color="red">Category: Lupus</font><br/><font color="blue">Published: 20-Mar-08</font><br/><font color="teal">Pages: 108</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pharmaceutical Supply chain strategies: Reassessing product distribution to cut costs and improve supply chain management]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2543</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Ideally drug supply should be a simple and transparent chain that connects the manufacturer and patient in as few steps as possible, however in practice it can be a highly circuitous one that includes several intermediaries before reaching ... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 20-Mar-08</font><br/><font color="teal">Pages: 64</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Biologics in Infectious Diseases  Well defined target populations are key to commercial success]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2542</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Antibody-based agents represent a novel approach to the treatment and prophylaxis of infectious diseases. In recent years, considerable interest has been expressed in their further development, driven by advances in technology that improve ... <br/><font color="red">Category: Monoclonal Antibodies</font><br/><font color="blue">Published: 21-Mar-08</font><br/><font color="teal">Pages: 123</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2541</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

With the AD market entering a pivotal phase, Datamonitor has conducted several scenario forecasts in order to explore the possible market outlook over the next 10 years. Several pioneering Phase III disease slowing therapies offer blockbust... <br/><font color="red">Category: Neurology</font><br/><font color="blue">Published: 26-Mar-08</font><br/><font color="teal">Pages: 222</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2540</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The opioid market is currently valued at $7.7 billion and is set to increase over the next 10 years at a CAGR of 2.4%. Despite this market being exclusively comprised of old genericized molecules, novel formulations and delivery methods hav... <br/><font color="red">Category: Pain</font><br/><font color="blue">Published: 26-Mar-08</font><br/><font color="teal">Pages: 233</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2539</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The Critical Care Community is currently at its most organized, and motivated, and on a mission to improve outcomes in sepsis. This is driving a rigorous assessment of care strategies which is gathering speed and showing results. This will ... <br/><font color="red">Category: Sepsis</font><br/><font color="blue">Published: 26-Mar-08</font><br/><font color="teal">Pages: 124</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2538</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[The Future of Targeted Therapeutics

In recent years, the maximization of blockbuster revenues has been compromised by generic price erosion and a decline in new drug approvals. Large pharmaceutical companies are coming under pressure to explore new R&D ... <br/><font color="red">Category: General</font><br/><font color="blue">Published: Mar-08</font><br/><font color="teal">Pages: 157</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2537</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Impact of Pharmacogenomics on Public Healthcare Policy

Immense advances in genetic code decipherment over the last decade have recently led to personalized medicine, or ‘the right drug for the right person’, becoming an achievable concept. Pharmacogenom... <br/><font color="red">Category: Genomics</font><br/><font color="blue">Published: Mar-08</font><br/><font color="teal">Pages: 171</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2536</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[The Fastest Growing Biotechnology Companies
In recent years, the biopharmaceutical industry has emerged as one of the most important sectors in the Healthcare field. Advances in life sciences have resulted in the drug discovery process becoming more scien... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: Mar-08</font><br/><font color="teal">Pages: 280</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[RFID in Pharmaceutical Manufacturing: Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2532</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process.  This Kalorama Information report discussions the solutions available, and covers the opportunities available to techn... <br/><font color="red">Category: RFID</font><br/><font color="blue">Published: 3/1/2008</font><br/><font color="teal">Pages: 100</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Worldwide Market for Cancer Diagnostics, 3rd Edition, The]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2534</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Who are the major players in testing for the number two killer in the world?  What revenues can companies competing in this market expect in the next five years?  How will the impact of trends such as an increased role of pharmacodiagnostics, the use of mu... <br/><font color="red">Category: Diagnostics</font><br/><font color="blue">Published: 3/1/2008</font><br/><font color="teal">Pages: 220</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Prescription Dermatological Drugs: Worldwide Market, 6th Edition]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2496</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders.  This edition of Worldwide Market for Presc... <br/><font color="red">Category: Dermatology</font><br/><font color="blue">Published: 1/1/2008</font><br/><font color="teal">Pages: 330</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World Cardiovascular Drug Market (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2342</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[As one of the most competitive pharmaceutical markets, keeping track of the cardiovascular drug market can be a difficult undertaking. The range of therapeutic options available to physicians has expanded significantly in the past few years, and will conti... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: 12/1/2007</font><br/><font color="teal">Pages: 265</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2533</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on disease... <br/><font color="red">Category: Stem Cells</font><br/><font color="blue">Published: 3/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[High-Tech Patient Monitoring Systems Markets (Remote and Wireless, Patient Data Processing, EMR Data transfer/interface Systems)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2531</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Novel technologies in patient monitoring are emerging to meet the increasing demands of an aging population, decreasing healthcare resources, and an emphasis on reducing hospital days.   Nearly all focus on some form of ambulatory monitoring using wired or... <br/><font color="red">Category: Monitoring</font><br/><font color="blue">Published: 3/1/2008</font><br/><font color="teal">Pages: 125</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2535</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Congestive heart failure is an increasingly important cause of cardiovascular morbidity and mortality. It is the number one cause of hospitalization among individuals aged 65 and over.  The United States Medicare system pays out more for the care of conges... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: 2/1/2008</font><br/><font color="teal">Pages: 220</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Using a Multi-faceted Approach to Increasing EHR Adoption (Strategy Focus)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2519</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions.

Scope

Identifies opportunities in... <br/><font color="red">Category: e-Healthcare</font><br/><font color="blue">Published: 16-Jan-08</font><br/><font color="teal">Pages: 12</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[2008 Trends to Watch: Pharmaceutical Technology]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2518</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Technology markets are changing fast. This brief identifies and tracks the key forces shaping the prospects for your business. In this piece, Datamonitor's analyst specializing in pharmaceutical technology will outline the changes in the ma... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 31-Jan-08</font><br/><font color="teal">Pages: 13</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[2008 Trends to Watch: Healthcare Technology]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2517</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Technology markets are changing fast. This brief identifies and tracks the key forces shaping your business. Datamonitor's healthcare technology analyst will outline the main business priorities in your market, explain which trends will hav... <br/><font color="red">Category: General</font><br/><font color="blue">Published: 31-Jan-08</font><br/><font color="teal">Pages: 13</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[GTC Biotherapeutics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2516</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

GTC Biotherapeutics is engaged in the development, production and commercialization of therapeutic proteins expressed and purified from the milk of transgenic animals such as goats and cattle. ATryn, the company's major product, is a recomb... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 1-Jan-08</font><br/><font color="teal">Pages: 48</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Neurogen Corporation: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2515</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Neurogen is a drug discovery and development company founded in 1987. The company established its presence in the pharmaceutical market by partnering with Pfizer and American Home Products in 1999. In addition, the company's proprietary tec... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 1-Jan-08</font><br/><font color="teal">Pages: 48</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[EPIX Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2514</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

EPIX Pharmaceuticals is a clinical-stage biopharmaceutical company focused on small molecule drug discovery and development with pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the ce... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 1-Jan-08</font><br/><font color="teal">Pages: 55</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Warner Chilcott Ltd: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2513</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Warner Chilcott is a specialty pharmaceutical company focused on two therapeutic segments: women's health and dermatology. The company's predecessor company was purchased by a private equity consortium in January 2005. The company has a str... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 1-Jan-08</font><br/><font color="teal">Pages: 55</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[GPC Biotech AG: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2512</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

GPC Biotech (GPC), founded in 1997, has a business model relied on two pillars, as a service provider for preclinical research and as a product company with its own development pipeline. Later, the company changed its focus by developing a ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 1-Jan-08</font><br/><font color="teal">Pages: 45</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[ArQule Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2511</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

ArQule, founded as a chemistry service company, became a drug discovery and development company by acquiring Cyclic Pharmaceuticals in 2003. The company's proprietary drug discovery platforms such as Cancer Survival Pathways and Activated C... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 1-Jan-08</font><br/><font color="teal">Pages: 47</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Sonus Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2510</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Sonus Pharmaceuticals's main focus is to discover, develop and commercialize products for the treatment of diseases in the therapeutic area of oncology. The company seeks to build a franchise of oncology products through its own internal ef... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 14-Jan-08</font><br/><font color="teal">Pages: 41</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[QLT Inc:  Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2509</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

QLT was originally focused on discovering, developing and commercializing innovative therapies in the fields of ophthalmology and dermatology. In 2006, the company changed its focus to purely research and development by selling its manufact... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 14-Jan-08</font><br/><font color="teal">Pages: 55</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Martek Biosciences Corp: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2508</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Martek Biosciences (Martek) is a life-science based company that develops and commercializes naturally produced products derived from microalgae, fungi and other microbes. It's research is focused on identifying and creating commercially vi... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 14-Jan-08</font><br/><font color="teal">Pages: 47</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Tanox: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2507</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Tanox identifies and develops therapeutic monoclonal antibodies to address significant unmet medical needs in the areas of immunology, infectious diseases and cancer. In January 2007, the stockholders of Tanox approved the merger with Genen... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 9-Jan-08</font><br/><font color="teal">Pages: 35</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Optimer Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2506</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Optimer Pharmaceuticals (Optimer) focuses on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The company currently has two late stage anti-infective produc... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 42</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Keryx Biopharmaceuticals: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2505</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Keryx Biopharmaceuticals (Keryx) is a development stage company involved in acquiring, developing and commercializing products for diabetes and cancer. Sulonex, the company's lead product candidate, is in Phase III/IV trials for diabetic ne... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 44</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cytokinetics Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2504</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Cytokinetics is the first company to systematically investigate the cytoskeleton and molecular motors as possible drug targets for cancer and cardiovascular diseases. The company applies proprietary technologies in the development of sophis... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 46</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cypress Bioscience Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2503</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Cypress Bioscience is a biotechnology company specializing in products for the treatment of patients with Functional Somatic Syndromes, such as Fibromyalgia Syndrome (FMS) and other central nervous system (CNS) disorders. In December 2007, ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 44</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Dynavax Technologies Corp: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2502</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Dynavax Technologies is a biopharmaceutical company that discovers and develops products for the treatment of infectious diseases, allergies, cancer and chronic inflammatory diseases. The company's principal product development efforts are ... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 53</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Alexza Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2501</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Alexza was founded in 2000 as FaxMed and changed its name to Alexza Corporation in June 2001 and to Alexza Molecular Delivery Corporation in December 2001. Further, it changed its name to its present one Alexza Pharmaceuticals in July 2005.... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 47</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Alexion Pharmaceuticals Inc: Premium Company Profile]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2500</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Alexion Pharmaceuticals (Alexion) is a biotechnology company engaged in the discovery and development of therapeutic products for the treatment of hematological diseases, cancer, and autoimmune disorders. The company started marketing Solir... <br/><font color="red">Category: Company Profiles</font><br/><font color="blue">Published: 13-Feb-08</font><br/><font color="teal">Pages: 52</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Cardiovascular Disorders Market Outlook to 2012]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2499</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[The Cardiovascular Disorders Market Outlook to 2012

Business Intelligence for the Pharmaceutical Industry
Business Insights' portfolio of healthcare management reports are designed to help you make well informed and timely business decisions. We unders... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: Feb-08</font><br/><font color="teal">Pages: 228</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Heart Health Food and Drinks: NPD in cardiovascular health, hypertension and cholesterol reduction]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2498</link>
			<author><![CDATA[Source: Business Insights]]></author>
		 <description><![CDATA[Business Intelligence for the Consumer Goods Industry
Business Insights' portfolio of consumer goods management reports are designed to help you make well informed and timely business decisions. We understand the problems facing today's consumer goods exe... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: Feb-08</font><br/><font color="teal">Pages: 59</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2497</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to... <br/><font color="red">Category: Arthritis</font><br/><font color="blue">Published: 1/1/2008</font><br/><font color="teal">Pages: 180</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[World Market for Catheters, The]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2495</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Catheters are among the world's oldest medical devices, but yet they are still critical part of the practice of medicine and surgery.  Companies seeking opportunities in this medical device market will want to utilize Kalorama Information's World Market fo... <br/><font color="red">Category: Medical Devices</font><br/><font color="blue">Published: 2/1/2008</font><br/><font color="teal">Pages: 165</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pharmaceutical Excipients for Oral Formulations, 2nd. Edition]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2494</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Pharmaceutical Excipients, especially those for solid oral dosage forms, have very much been taken for granted and, until recently, have been largely ignored by chemical excipient suppliers, as well as by pharmaceutical formulating companies and end-users.... <br/><font color="red">Category: Drug Development</font><br/><font color="blue">Published: 2/1/2008</font><br/><font color="teal">Pages: 131</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2493</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality.  With improvements in the care of ... <br/><font color="red">Category: Cardiology</font><br/><font color="blue">Published: 2/1/2008</font><br/><font color="teal">Pages: 250</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial Insight: Autoimmune Overview - Market continues to prosper]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2489</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The autoimmune disease market will be rapidly growing due to a high number of competitive brands currently on the market and a full pipeline. Company strategies include expanding the treatment algorithm by pursuing approval for 'early' dise... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 26-Dec-07</font><br/><font color="teal">Pages: 285</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Anti-Counterfeiting Strategies - Combating Fake Pharmaceuticals]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2473</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Counterfeit medicines are a global problem costing patient's their health and the pharmaceutical industry and governmental organizations millions of dollars per year. Although there is no one preventative strategy, there are several measure... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 19-Dec-07</font><br/><font color="teal">Pages: 115</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[The Pharmaceutical Company Outlook to 2012: Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2482</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Based on an analysis of 43 companies and 1,200+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 3.2% CAGR 2006 to 2012. However, behind this industry average figure there are strategic se... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 25-Dec-07</font><br/><font color="teal">Pages: 160</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion at Patent Expiry]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=1756</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

With declining returns from drug development pipelines, preservation of branded revenues is key for manufacturers. Inevitably though, once the core product patent of a pharmaceutical drug expires, generic companies will launch their own, ch... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 9-Apr-07</font><br/><font color="teal">Pages: 99</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=1757</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Novel oral anticoagulants and antiplatelet agents will have a profound impact on the antithrombotics market. Datamonitor expects Bayer's rivaroxaban and Sankyo/Eli Lilly's prasugrel to achieve blockbuster status. Parenteral anticoagulants a... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 9-Apr-07</font><br/><font color="teal">Pages: 257</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2254</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Sales of the Top 20 cancer therapy brands in each of the seven major markets totaled $24.5 billion in 2006 and are forecast to grow at a CAGR of 6.6% to $45.9 billion by 2016. Four newly marketed drugs are expected to become part of the Top... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 02-Jul-07</font><br/><font color="teal">Pages: 221</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Disease Management and Drug Adherence:  Strategies to support patients and enhance treatment persistence]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2252</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Failure to take medication as prescribed significantly increases the risk that patients will experience complications resulting in injury or death, and propagate higher healthcare costs overall. The medical establishment's approach to adher... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 02-Jul-07</font><br/><font color="teal">Pages: 128</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2256</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Detailed analysis of the Asthma and COPD market. 10 year sales forecast for all major drugs brands in these indications, taking into account new treatment trends, clinical trial data, patent expirations and key new product launches in the 7... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 11-Jul-07</font><br/><font color="teal">Pages: 269</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Commercial Insight: HIV - Reshaping Treatment Paradigms]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2257</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Detailed analysis of the antiretroviral therapy market. 10 year sales forecast for marketed drugs and key pipeline compounds, factoring in clinical trial results, new product launches and patent expiries.

Scope

In-depth analysis of th... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 11-Jul-07</font><br/><font color="teal">Pages: 194</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Patient Empowerment: empowered patients can change healthcare outcomes and impact the pharmaceutical industry]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2307</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Datamonitor has identified the key trends and events that drive patient empowerment and impact the pharmaceutical industry. These range from the increased access to information via internet and the rising pressures of cost containment throu... <br/><font color="red">Category:   Special price offers!</font><br/><font color="blue">Published: 20-Jul-07</font><br/><font color="teal">Pages: 111</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Gene Expression Profiling Markets]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2491</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile.  The main products—microarrays and RT-PCR—continue to gain widespread acceptance and t... <br/><font color="red">Category: Gene Expression</font><br/><font color="blue">Published: 12/1/2007</font><br/><font color="teal">Pages: 169</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Pipeline and Commercial Insight: Urinary Incontinence - Lifecycle management strategies retain mid-term market growth]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2488</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

The UI market is set to continue to grow over the next 6 years, reaching over $2.5 billion in 2012, a 68% increase from 2006. Lifecycle management strategies, novel formulations and follow-on products will drive the majority of this growth,... <br/><font color="red">Category: Urology</font><br/><font color="blue">Published: 26-Dec-07</font><br/><font color="teal">Pages: 185</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Organ Transplant Immunosuppressive Markets]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2492</link>
			<author><![CDATA[Source: Kalorama Information]]></author>
		 <description><![CDATA[Improved surgical techniques and organ preservation, understanding of immunologic barriers, and the development of newer and more potent immunosuppressives have combined to improve survival of transplant patients and grafts. Rejection remains the major bar... <br/><font color="red">Category: Organ Transplant</font><br/><font color="blue">Published: 12/1/2007</font><br/><font color="teal">Pages: 160</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stakeholder Opinions: Hepatitis C - Small-molecule antivirals pave the way for triple therapy]]></title>
			<link>http://salesandmarketingnetwork.com/reports.php?ID=2490</link>
			<author><![CDATA[Source: Datamonitor]]></author>
		 <description><![CDATA[Introduction

Research and Development activity in the Hepatitis C arena continue to be high. The market still holds many areas of unmet medical needs: while existing therapies provide good efficacy for about half of the patient population, side effects ... <br/><font color="red">Category: Hepatitis</font><br/><font color="blue">Published: 19-Dec-07</font><br/><font color="teal">Pages: 142</font>]]>
			</description>
	</item>
	</channel>
</rss>